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Abstract 19 
We evaluated the efficacy of a new disinfectant product, HLE, to inhibit multiple 20 
species of planktonic and biofilm bacterial cultures. The HLE disinfectant comprised of 21 
EDTA, lactic acid and hydrogen peroxide, and our data indicated that the disinfectant 22 
had effective antimicrobial and anti-biofilm activity even at low concentrations (0.15% 23 
to 0.4% HLE, v/v). Furthermore, the HLE disinfectant destabilized biofilm structures 24 
eradicated them due to the synergistic effect of EDTA and both antimicrobials (lactic 25 
acid and hydrogen peroxide), as revealed by confocal laser scanning microscopy. 26 
Additionally, sub-inhibitory concentrations of HLE disinfectant, with EDTA as an 27 
efflux pump inhibitor, inhibited the expression of multidrug EfrAB, NorE and MexCD 28 
efflux pumps in both planktonic and biofilm cultures. This could provide an alternative 29 
way to disinfect surfaces to avoid spreading multi-drug resistant strains in the food 30 
chain and the environment by decreasing efflux pump expression and consequently 31 
reducing the antibiotic selective pressure caused by systemic antibiotics and disinfectant 32 
use. 33 
 34 
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1. Introduction 
Bacterial biofilms are complex structures comprising of a consortium of multiple 
species of microorganisms. They prevail as part of the bacterial lifestyle as they 
contribute a crucial role in protecting bacterial populations from environmental 
hardships (e.g., exposures to antimicrobials, pH change, osmotic shock, UV radiation 
and several stresses), and they also provide enhanced nutrient availability, removal of 
toxic metabolites, and facilitate the acquisition of new genetic traits (Donlan and 
Costerton, 2002; Kokare et al., 2008). These irreversible microbial aggregations form 
on most surface types, including:  plastic, metal, wood, glass, medical devices, tissues, 
implants, food products and soil particles. Thus, they become a source of contamination 
in food preparations, water sources and medical settings.  
From the public health perspective, biofilm control in the food industry and medical 
settings poses an arduous task and responsibility since their presence is associated with 
increased threat of drug resistance to society and pharmaceutical industries, and thus 
diminishing the efficacy of chemical treatments and therapy. Several types of bacteria 
develop their resistance to disinfectants, and other antimicrobial agents, by forming 
biofilms to limit the diffusion of chemicals through the exopolysaccharide (EPS) matrix 
as an effective physical barrier (McDonnell and Russell, 1999). Further, biofilm 
antimicrobial resistance involves additional multifaceted responses including intrinsic 
factors, e.g.: the matrix, micro-environments, small sub-populations as persisters, and 
oxidative-stress responses; and the extrinsic or induced resistance factors, e.g.: 
increased mutation, increased horizontal gene transmission, production of antibiotic 
degradative enzymes, targets with lowered affinity, and over-expression of efflux 
pumps with broad range of substrate targets (Paraje, 2011). Therefore, the eradication 
and elimination of these highly resistant structures, which serve as protective niches, 
including for bacterial pathogens, remains a big challenge, and these intrinsic and 
extrinsic resistance factors work synergistically to enhance their survival. To address 
this growing problem, new disinfection strategies are required to prevent biofilm 
formation and reduce (or to avoid) the spread of biofilm-forming bacteria and their 
resistance genes in different ecosystems.  
Current literature reports several disinfection products and their efficacies; however, 
the over-use of disinfectants containing some biocides such as quaternary ammonium 
compounds may increase resistance traits (e.g, Buffet-Bataillon et al., 2012; Hegstad et 
al., 2010). As the biocides diffuse into the biofilm matrix, they generate an 
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antimicrobial gradient that promotes differential gene expression and triggering of 
different antimicrobial-induced factors through the biofilm (Costerton et al., 2003; 
Macfarlane and Dillon, 2007).  
Here, we developed a new disinfection product, HLE, that contains natural 
substances (hydrogen peroxide, lactic acid and EDTA) and avoids quaternary 
ammonium compounds or toxic detergents; rather, we strategically aimed to utilize 
compounds that synergistically eradicate preformed biofilms and inhibit further biofilm 
establishment on different surfaces. Furthermore, we analysed the effect of HLE on the 
expression of efflux pump genes, which is a means of spreading antimicrobial resistance 
in the environment.  
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2. Materials and Methods 
2.1. Bacterial strains and growth conditions 
Staphylococcus aureus CECT 4468, Listeria monocytogenes CECT 4032, 
Enterococcus faecalis S-47, Bacillus cereus CECT 5148, Escherichia coli CCUG 
47553 and Salmonella Enteritidis UJ3449 were used in this study on the basis of their 
pathogenic character, their ability to form biofilms, and their resistance to 
antimicrobials. Strains were cultured in Tryptone Soya Broth (TSB) (Fluka, Madrid, 
Spain) at 37°C for 24 h. Cultures were maintained in 20% glycerol at -20°C and -80°C 
for short- and long-term storage, respectively. 
 
2.2. Effect of HLE antimicrobial product on planktonic cell growth 
To determine the minimum inhibitory concentrations (MIC) and the minimum 
bactericidal concentrations (MBC) of HLE (3-6% H2O2, 2.2-4.4% lactic acid and 12.5-
25 mM EDTA in water), we used the broth micro-dilution method. Overnight bacterial 
cultures, grown in TSB broth at 37ºC for 24 h, were diluted 1/10 (v/v) in fresh TSB 
broth and 20 µl were added to each well of 96-well microtiter plates. 180 µl of TSB 
broth supplemented with HLE at different concentrations (0.25-50%, v/v) were then 
added to the wells and incubated at 37ºC under aerobic conditions for 24 h. Bacterial 
growth was evaluated by the presence of turbidity. From wells that lacked turbidity, 
cells were subjected to viable count determination (CFU/ml; colony-forming units) by 
plating 10 µl-samples on Tryptone Soya Agar (TSA) and incubated at 37ºC for 24 h. 
MIC was defined as the lowest concentration of HLE that inhibited visible growth, and 
MBC was defined as the lowest concentration of HLE that killed bacteria (>99% 
removal). Each experiment was done in triplicate. 
 
2.3. Determining the effect of HLE on biofilm development 
The anti-adhesion properties of HLE to different bacterial strains (S. aureus CECT 
4468, L. monocytogenes CECT 4032, E. faecalis S-47, B. cereus CECT 5148, E. coli 
CCUG 47553 and S. Enteritidis UJ3449) and a cocktail (mixture) of all strains were 
tested in microtiter plates. Overnight bacterial cultures, grown in TSB broth at 37ºC for 
24 h, were diluted 1/10 (v/v) in fresh TSB broth, and 20 µl were added to each well of 
the microtiter plate. The wells were then added with 180 µl of TSB broth supplemented 
with HLE at sub-MIC concentrations (ranging from ½-level of MIC for each strain to its 
full MIC). Controls without HLE consisted solely of 180 µl of TSB broth. Plates were 
 6 
incubated at 37ºC under aerobic conditions for 24 h, and the wells were then washed 
with 200 µl of phosphate buffered saline (PBS). The anti-adhesion activity of HLE was 
determined by staining the washed wells with 100 µl of 1% (w/v) crystal violet and 
allowing them to incubate at room temperature for 15 min. Then, 200 µl PBS were 
added to the wells, and the absorbance at 590 nm was determined using a microplate 
reader (iMark Microplate Absorbance Reader, Bio-Rad instrument). The percentage of 
inhibition of biofilm formation was determined using the following formula as 
described by Zmantar et al. (2017): 
 
 
2.4. Antimicrobial effect of HLE on preformed biofilms  
Inoculum of 1% of each bacteria and the cocktail of all strains in TSB was used for 
the preparation of biofilms, which were grown in 96-well microtiter plates for 24 h at 
37°C. After incubation, the culture broth containing non-adhered bacteria was removed 
and the wells were then washed with sterile PBS. The biofilms were treated with HLE 
(100%) for different time periods (5, 10, 15, 20 and 30 min) at room temperature. After 
treatments, HLE was removed and the wells were incubated ZLWK  ȝO RI '(
Neutralizing broth (Difco, Barcelona) for 5 min at room temperature and then they were 
washed with  ȝO RI 3%6 %LRILOPV ZHUH UHVXVSHQGHG LQ  ȝO 3%6 DQG serially 
diluted (with PBS) before plating on TSA. The plates were incubated at 37ºC for 24 h 
for the determination of CFU/ml. 
 
2.5. Microscopic evaluation of HLE effects on biofilms 
Imaging of HLE-treated biofilm was done by using LIVE/DEAD %DF/LJKW
(Thermo Fisher Scientific, Waltham, MA, USA) and a confocal laser scanning 
microscope (LEICA TCS-SP5, Mannheim, Germany) equipped with the Plan-
Apochromat 63x/1.4 objective. After biofilm cultivation on a microtiter plate (200 µl) 
as described above, some wells were not treated with HLE (Control) and the other ones 
were subjected to HLE treatment for 5 and 10 min at room temperature (HLE-treated 
samples), washed with sterile PBS and resuspended in 50 µl PBS. Then, 20 µl of the 
suspensions (Control and HLE-treated) were amended with 0.5 µl of LIVE/DEAD 
stain, subsequently spotted on a glass slide, and imaged using a confocal laser scanning 
microscope. Alternatively, preformed biofilms on sterile glass slides were subjected (or 
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not, as controls) to the effect of HLE for 5 and 10 min durations at room temperature as 
described above; however, staining was done directly on the slides and then imaged 
using a confocal laser scanning microscope. 
 
2.6. PCR amplification to detect efflux-pump genes  
Total DNA extractions were done using ZymoBIOMICS DNA Miniprep Kit (Zymo 
Research, California, USA) according to the manufacturer´s instructions. DNA 
quantification and quality assessment were carried out by using a NanoDrop 2000 
spectrophotometer (Thermo Scientific). PCR amplification of well-known structural 
genes of efflux pumps (EfrAB, AcrA, NorA, NorE, MefA, QacC, YvcC, EvgA, 
MexAB, MexCD, MexXY) was done as described elsewhere (Oh et al., 2004; Lee et 
al., 2003; Nishino and Yamaguchi, 2002; Patel et al., 2010; Smith and Hunter, 2008; 
Steinfels et al., 2004; Sutcliffe et al., 1996; Swick et al., 2011).  
 
2.7. Effect of sub-inhibitory HLE concentrations on efflux-pump gene expression 
Six bacterial strains (1%) were each dosed (or not, as a control) with ½-level of MIC 
of HLE in TSB broth (2 ml) and then incubated for 18 h at 37ºC in either sterile tubes 
(for planktonic cell growth) or in 24-well microtiter plate for biofilm formation. RNA 
extraction was done using Direct-]RO 51$ Miniprep (Zymo Research, California, 
USA) according to the manufacturer´s instructions. RNA quantification and quality 
assessment were carried out by using a NanoDrop 2000 spectrophotometer (Thermo 
Scientific). RNAs were adjusted to a concentration of 500 ng/ml and frozen at -80 ºC 
until required for analysis.  
The expression of efrA and efrB genes (coding for EfrAB), and norE (coding for 
NorE) gene by both the planktonic cells and biofilms (controls and treated samples with 
½-MIC and ¾-MIC of HLE) was determined by quantitative, real-time PCR (qRT-
PCR) using SensiFASTTM SYBR & Fluorescein One-Step Kit (BIOLINE). 
Phenylalanyl-tRNA synthase alpha-subunit (pheS) gene was used as a housekeeping 
gene, and a no-template control (NTC) was used as negative control. Primers and 
annealing temperatures used in this study are described in Table 1. Quantitative PCRs 
(qPCRs) were performed in triplicate on a CFX96 TouchTM Real-Time PCR Detection 
System from BioRad using 2 Power SYBR green chemistry. PCR-grade water served as 
a negative control.  
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2.8. Statistical analysis 
All analyses were performed in triplicate. Statistical analyses were conducted using 
Excel 2007 (Microsoft Corporation, Redmond, Washington, US) program to determine 
means and standard deviations. Statistical evaluation of the effect of HLE on biofilm 
development assays were conducted by analysis of variance (ANOVA) using 
Statgraphics Centurion XVI software (Statpoint Technologie, Warrenton, Virginia, US). 
The same software was used to perform Shapiro±Wilk and the Levene tests to check 
data normality and to perform two-VLGHG 7XNH\¶V PXOWLSOH FRQWUDVW WR GHWHUPLQH WKH
pair-wise differences between strains, where level of significance was set at P-value of 
< 0.05. 
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3. Results 
3.1. Antimicrobial activity of HLE on planktonic cells 
Table 2 shows the MICs and MBCs of HLE for the different bacterial strains used in 
this study and also the cocktail (mixture) of six bacterial strains. Planktonic cells had 
great susceptibilities, exhibiting lower MICs ranging from 0.15% to 0.4% HLE (v/v), 
with L. monocytogenes CECT 4032 and E. faecalis S-47 being the most susceptible 
strains. S. aureus CECT 4468 was the least susceptible (Table 1). The MBC values very 
similarly ranged from 0.2% to 0.5% HLE (v/v). As such, the HLE disinfectant 
effectively inhibited and killed Gram-positive and Gram-negative bacteria; furthermore, 
the cocktail comprising of the six bacteria was also inhibited by a low concentration of 
HLE (0.5%) (Table 2). 
 
3.2. HLE inhibition of biofilm formation   
Strong inhibition of biofilm development was achieved using the MIC of HLE for 
each bacterial strain/cocktail, and the results showed 80-91% inhibition of developing 
biofilm was achieved for individual strains and also the cocktail (Table 3). Furthermore, 
the use of ½-level of MIC of HLE provided 33-50% inhibition of biofilm development 
(Table 3). These results indicate that HLE impacted bacterial adherence to polystyrene 
depending on the bacterial strain (Table 3). 
 
3.3. Evaluation of antimicrobial effect of HLE on biofilms  
Preformed biofilms (24 h) of each bacterial strain were exposed to HLE for several 
contact times (5, 10, 15, 20 and 30 min) in microtiter plates. The results demonstrated 
that HLE had bactericidal effects against all bacterial strains at all contact times (5 - 30 
min.; Fig. 1). Furthermore, confocal microscopy revealed that HLE decreased the 
viability of many cells (stained in green) in treated biofilms (5 and 10 min; Fig. 2B-D) 
versus untreated controls (Fig. 2A); as such, only dead cells (stained in red) were 
visualized (Fig. 2C and D).  
Multi-species biofilms²formed on glass slides, treated with HLE, and stained with 
LIVE/DEAD BacLightTM²exhibited strong susceptibility to the bactericidal effect of 
HLE. Figure 3 shows that the HLE-treated biofilms exhibited larger channels amongst 
the bacterial aggregates, and no viable cells were observed after 10 min exposure to 
HLE, when compared with the control (Fig. 3). 
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3.4. Effect of HLE on efflux-pump gene expression 
PCR amplification of different genes related to efflux pumps revealed only the 
presence of efrA and efrB in all bacteria; however, norE and mexD genes were detected 
in some strains (norE gene was detected in all bacteria except L. monocytogenes CECT 
4032 and B. cereus CECT 5148; mexD gene was detected in all bacteria except S. 
aureus CECT 4468). Thus, to check whether a low concentration of HLE had any 
inhibitory effect, mRNA levels from efrA, efrB, norE and mexD genes were quantified 
from both planktonic and biofilm cells. The results showed differential expression of 
efrA, efrB, norE and mexD genes depending on the physiological state of the bacteria 
(planktonic or biofilm). In general, the expression of efflux-pump genes in biofilms was 
remarkably lower than those in related planktonic cells, which were 50x higher when 
not treated with HLE (data not shown). Furthermore, sub-inhibitory concentrations (½-
level of MIC and ¾-level of MIC) of HLE inhibited the expression efrA, efrB, norE and 
mexD genes in planktonic cells, with the differences in mRNA levels being statistically 
significant (Fig. 4A). Similarly, biofilms formed in the presence of sub-inhibitory 
concentrations (½-level of MIC and ¾-level of MIC) of HLE had decreased expression 
of all multidrug efflux pump genes, versus the controls without HLE exposure (Fig. 
4B).  
In all cases, the down-regulation of EfrAB, NorE and MexCD efflux-pump gene 
expression caused by HLE was more remarkable in planktonic cells than biofilms (Fig. 
4). However, the HLE impacted gene expression in all cells. 
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4. Discussion 
A bLRILOP¶V increased tolerance to antimicrobial agents (e.g., biocides and 
antibiotics) represents a serious problem in the food industry and medical settings, 
which leads to substantial economic and health concerns related to contamination and 
infections (Bridier et al., 2011; Davies, 2003; Stewart, 2015). Biofilm formation occurs 
within both the natural and medical environments, and their tolerance to antimicrobials 
has been largely documented by in vitro and in vivo studies (Davis et al., 2008; Sabir et 
al., 2017). Food processing plants provide conditions for biofilm proliferation (e.g., 
abundant source of nutrients), and nowadays there are no strategies that inactivate or 
completely remove biofilms ZLWKRXW XQGHVLUDEOH HIIHFWV 6LP}HV et al., 2010). 
Furthermore, multi-species biofilms complicate effective eradication due to synergistic 
interactions among microbes and their enhanced tolerance/virulence. Thus, the 
eradication or control of biofilm formation remains an important issue, especially when 
biofilms are pathogenic.  
As such, we investigated HLE disinfectant on growing and mature biofilms 
comprised of Gram-positive (spore-forming and non spore-forming bacteria) or Gram-
negative bacteria, and a combination of both. Firstly, low concentrations of HLE 
demonstrated to be inhibitory (MIC of 0.15% to 0.4% HLE, v/v) and bactericidal (MBC 
of 0.2% to 0.5% HLE, v/v) to planktonic cells. Preformed biofilms, however, required 
greater HLE concentrations and contact times (data not shown). Key factors 
contributing to ELRILOPV¶ increased resistance versus planktonic cell state include the 
physiological heterogeneity of cells (e.g., those that are growing, stress-adapted, 
dormant, inactive), differences in gene expression, low diffusion of antimicrobials 
through the matrix, or the direct interaction of exopolysaccharides with antimicrobials. 
As reviewed by Mah and O´Toole (2001), cells within a biofilm can become 10±1000 
times more resistant to antimicrobial agents; so, susceptibility differences between cells 
in plankton versus biofilm states were not surprising, but in this experiment they were 
(by comparison to aforementioned range in literature) relatively minimal. Thus, we 
demonstrated the effective eradication of preformed biofilms of Staphylococcus aureus 
CECT 4468, Listeria monocytogenes CECT 4032, Enterococcus faecalis S-47, Bacillus 
cereus CECT 5148, Escherichia coli CCUG 47553 or Salmonella Enteritidis UJ3449 
and also the cocktail (a mixture of the six strains) with HLE treatment after 5 min at 
room temperature. Additionally, the HLE disinfectant inhibited biofilm formation at 
lower concentrations: 33-50% inhibition at ½-level MIC or 80-91% at full MIC (0.15% 
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to 0.4% HLE, v/v). As such, surface biofilm formation could be prevented by the 
application of HLE disinfectant at low concentration.  
The composition of the HLE disinfectant in this study consisted of 3-6% hydrogen 
peroxide, 2.2-4.4% lactic acid and 12.5-25 mM EDTA, and the contact time for 
complete eradication of individual and multispecies biofilms was 5 min at room 
temperature (Submitted Patent OEPM P201731462).  
Lactic acid and hydrogen peroxide are amongst the antimicrobial substances 
commonly produced by lactic acid bacteria (LAB), in addition to bacteriocins, other 
organic acids and diacetyl (Salminen, 1995). Lactic acid, as the unique or the 
predominant fermentation product in homo-fermentative and hetero-fermentative LAB 
(respectively), plays a crucial role in food preservation with concentrations up to 8% in 
fermentation process (Urbonaviciene et al., 2015), and the antimicrobial properties of 
lactic acid have been widely reported to inhibit bacterial growth by disrupting 
cytoplasmic membranes, leading to the loss of proton motive force and leakage of 
intracellular ions (e.g., Alakomi et al., 2000; Ricke, 2003). Similarly, Wang et al. (2015) 
indicated that 0.5% lactic acid sufficiently inhibits the growth of planktonic Salmonella 
Enteritidis, E. coli and L. monocytogenes; further, they observed the release of 
intracellular proteins and suggested that lactic acid caused physiological and 
morphological changes in bacterial cells. Furthermore, from the safety point of view, 
lactic acid is not carcinogenic and does not pose any chronic risk to human health or the 
environment (Boomsma et al., 2015).  
Regarding hydrogen peroxide, it denatures many enzymes and protein thiol groups; it 
also causes the peroxidation of membranes, which leads to increased permeability and 
loss of cell integrity (Denyer and Stewart, 1998). Its mode of action depends on the 
target microorganism (Araújo et al., 2011); the biocide may act on the cytoplasm of 
bacteria, on the core of a bacterial spore, the ribosome of fungi, and the thiol groups of a 
virus. However, several studies have reported the high resistance of biofilms 
(Khakimova et al., 2013; Leung et al., 2012) due to catalase-producing bacteria that 
may exist in the matrix and thus neutralize the hydrogen peroxide. Interestingly, S. 
aureus, L. monocytogenes, E. coli and B. cereus, used in this study, represent catalase-
producing bacteria; however, the synergistic effect of all antimicrobials in HLE still led 
to effective eradication of their biofilms. On the other hand, several studies have shown 
that hydrogen peroxide, or any other biocide alone, is ineffective in eliminating biofilms 
 13 
completely (Lin et al., 2011; Smith and Hunter, 2008), suggesting combination of 
approaches is often required for effective biofilm control. 
EDTA is a known as metal-chelating agent, which destabilizes bacterial cell walls 
and biofilms by sequestering divalent cations (i.e., calcium, magnesium, zinc, and iron) 
required for growth and maintenance of cell structure, thus impacting several other 
cellular processes. For those reasons, its incorporation into several antimicrobial 
formulations with alcohol, antibiotics, organic acids, quaternary ammonium 
compounds, iodine and surfactants often improved their efficacy against biofilms (Kite 
et al., 2005; Lambert et al., 2004). In this study, the inclusion of EDTA as an 
antimicrobial and anti-biofilm agent (Finnegan and Percival, 2015) has shown a 
synergistic effect with the other compounds in the HLE (i.e., lactic acid and hydrogen 
peroxide), since individual components of HLE showed less antimicrobial effect on 
multi-species biofilms, i.e., less than 50% biofilm eradication when compared with HLE 
after 5-min exposure (data not shown). Thus, the synergistic effect of all HLE 
components contributed to the effective elimination of mono- and multispecies biofilms 
after 5-min exposure at room temperature, inhibition of biofilm (80-91%) development 
at 0.15% to 0.4% HLE v/v, and also complete eradication of pre-formed biofilms. 
Regarding the effect of HLE on biofilm structure, confocal laser scanning 
microscopy revealed that treated biofilms had a greater porous structure with larger 
channels among the cell clusters versus the control. This suggests that the HLE 
disinfectant produces a biofilm structure with greater clusters of dead bacteria. 
Furthermore, it has been reported that EDTA has an inhibitory effect on multidrug 
efflux pumps (i.e., as an efflux pump inhibitor, ³(3,´ in E. coli, Pseudomonas 
aeruginosa and Enterococcus sp. by decreasing their gene expression, and thus allowing 
other antimicrobial agents to accumulate in the bacterial cells and resulting in greater 
impairment on cellular functions (Chaudhary and Payasi, 2012; Chaudhary et al., 2012; 
Lavilla Lerma et al., 2014). In this study, we explored the effect of sub-inhibitory 
concentrations (i.e., ½- and ¾-levels of MIC) of HLE (containing EDTA as an EPI) on 
the expression of genes encoding for EfrAB, NorE and MexCD multidrug efflux 
pumps. Our data revealed that sub-inhibitory concentrations of HLE decreased the 
expression of EfrAB, NorE and MexCD MDR efflux pumps. This study represents the 
first report describing the role of EDTA as an EPI on NorE and MexCD pumps; in this 
manner, it has been shown that EDTA acts as a multi-drug-resistance (MDR), efflux-
pump inhibitor for: NorE²a member of the major facilitator superfamily (MFS);  
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EfrAB±an ATP-binding cassette (ABC) pump; and MexCD²which belongs to RND-
family drug efflux pumps. It was reported by Kvist et al. (2008) that other EPIs such as 
NMP, PAßN and Thioridazine blocks the activity of several efflux pumps (AcrAB, 
AcrEF, MexAB, MexCD, MexEF, NorA) and also biofilm formation in many bacteria. 
Further, it was reported by Lavilla Lerma et al. (2014) that EfrAB, a multidrug efflux 
pump, was generally implicated in the resistance of different antibiotics and biocides in 
enterococci isolated from fermented foods, and 3-mM EDTA effectively down-
regulated its gene expression and reduced the MICs of almost all antibiotics tested 
against the bacteria. As such, the EDTA present in HLE can diminish efflux-pump gene 
expressions in multiple cultures and synergistically enhance the antibacterial effects of 
lactic acid and hydrogen peroxide. As such, EfrAB, NorE and MexCD efflux pumps 
could be attractive targets for inhibition, not only in the food industry, but also in 
medical setting.  
Bacterial biofilms and planktonic cells exhibit differences in growth and metabolic 
rates, and also the regulation of many genes including those encoding for efflux pumps 
as strategy for waste management. In this sense, Zhang and Mah (2008) and Kvist et al. 
(2008) showed that efflux pumps were highly active in bacterial biofilms, as they exude 
toxic metabolites that accumulate when cells grow in close proximity; unfortunately this 
contributes to their antimicrobial resistance. As such, EDTA inhibiting efflux pumps 
and impacting biofilm formation could have lasting effects on the bacteria and help 
prevent resistance development. Although disinfection may be accomplished with 
diluted HLE (½-level of MIC) and the subsequent growth inhibition is not completely 
achieved, the spread of multidrug resistant strains could be avoided by consequently 
increasing the susceptibility of microbes to other antimicrobials. In this study, HLE 
effectively eradicates multi-species biofilms; at sub-inhibitory concentrations, it impacts 
biofilm formation and efflux pump expression, thus decreasing the risk of antibiotic-
selective pressures caused by the sole use of systemic antibiotics or disinfectants. 
 
 
5. Conclusions 
The present study demonstrated that HLE disinfectant effectively inhibited 
planktonic cells and biofilm establishment with low concentrations of HLE. 
Furthermore, HLE disinfectant eradicated preformed biofilms and destabilized their 
structure. Further, sub-inhibitory concentrations of the disinfectant inhibited the 
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expression of multidrug EfrAB, NorE and MexCD efflux pumps, which could represent 
a good alternative to avoid the spread of these multidrug resistant bacteria in the food 
chain and also the environment, and consequently minimizing the selective pressures by 
the use of systemic antibiotics and disinfectants. 
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Figure legend 
 
Figure 1. Antibacterial activity of HLE (100%) on mono- and multi-species biofilms 
(the cocktail of six bacteria: Staphylococcus aureus CECT 4468, Listeria 
monocytogenes CECT 4032, Enterococcus faecalis S-47, Bacillus cereus CECT 5148, 
Escherichia coli CCUG 47553 and Salmonella Enteritidis UJ3449) as determined by 
viable count (Log10 CFU/ml) after 0 min (Control), 5 min (T5), 10 min (T10), 20 min 
(T20) and 30 min (T30) exposure at room temperature.  
 
Figure 2. Confocal laser scanning microscopy images of multi-species biofilms after 
treatment with HLE disinfectant, suspension and staining with the BacLight Live/Dead 
viability kit (Invitrogen). The treated biofilms with HLE (100% v/v) disinfectant during 
0 min (A, Control), 2 min (B), 5 min (C) and 10 min (D) HLE exposure at room 
temperature were resuspended in PBS and stained. All images were obtained using 
confocal microscope (x63 objective) and digital zoom of 2.5x (A and D), 1.5x (C) and 
1x (B). 
 
Figure 3. Confocal laser scanning microscopy images of multi-species biofilms (grown 
on glass slides) after treatment with HLE disinfectant and staining with the BacLight 
Live/Dead viability kit (Invitrogen). The biofilms were treated with HLE (100% v/v) 
disinfectant during 0 min (A, Control), 5 min (B) and 10 min (C) HLE exposure at room 
temperature. All images were obtained using confocal microscope (x63 objective; 3x 
digital zoom) (A, B and C). The arrows indicate the channels among the bacterial 
clumps. 
 
Figure 4. Effect of sub-inhibitory HLE concentrations (½-level of MIC and ¾-level of 
MIC) on the expression of EfrAB, NorE and MexCD efflux-pump genes in planktonic 
cells (A) and biofilms (B).  
